KENNEDY CAPITAL MANAGEMENT LLC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 884589
ST LOUIS, MO
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,425,983
+$2,103,557 QoQ
Shares Held
256,608
-2.9% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#50
of 223 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. EWTX ranks #16 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in EWTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,425,983 | 256,608 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,322,426 | 264,204 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,993,045 | 241,509 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,065,088 | 250,622 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,310,589 | 252,524 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,943,400 | 224,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,318,341 | 236,642 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,059,243 | 227,023 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,899,998 | 272,071 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,349,153 | 293,265 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,750,932 | 342,864 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||